跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lodi - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lodi
Approved
STANDARD
Lodi
Hizon Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
373069ea4cd7ceb2
Company
Hizon Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
373069ea4cd7ceb2
Drug Approval Philippines Name
Lodi
Product Name
Lodi
Registration Number
DRP-1334-07
Brand Name
Lodi
Generic Name
Amlodipine (as besilate)
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Hizon Laboratories, Inc.
Distributor
GX International, Inc.
Issuance Date
29 December 2023
Expiry Date
05 February 2029
Pharmacologic Category
Antihypertensive
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
373069ea4cd7ceb2
Type
Standard
Back to Philippines FDA Approvals